29 participants
Short-course RT Followed by NALIRIFOX Plus Pucotenlimab as Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer With MSS/pMMR
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-16
- Start Date:
- 2026-05-31
- Completion:
- 2027-12-31
Conditions
- Advanced Rectal Cancer
Interventions
- DRUG
No Results Yet